State Variation in the Use of Non-Acute Coronary Angiograms and Coronary Revascularization Procedures.
作者信息
Wadhera Rishi K, Shen Changyu, Secemsky Eric A, Strom Jordan B, Yeh Robert W
出版信息
JACC Cardiovasc Interv. 2018 May 14;11(9):912-913. doi: 10.1016/j.jcin.2018.03.039.
Abstract
摘要
相似文献
1
State Variation in the Use of Non-Acute Coronary Angiograms and Coronary Revascularization Procedures.
JACC Cardiovasc Interv. 2018 May 14;11(9):912-913. doi: 10.1016/j.jcin.2018.03.039.
2
Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program.
J Am Heart Assoc. 2017 Sep 12;6(9):e006336. doi: 10.1161/JAHA.117.006336.
3
Coronary Angiography and Intervention in Women Resuscitated From Sudden Cardiac Death.
J Am Heart Assoc. 2020 Apr 7;9(7):e015629. doi: 10.1161/JAHA.119.015629. Epub 2020 Mar 25.
4
Factors associated with the rates of coronary artery bypass graft and percutaneous coronary intervention.
BMC Cardiovasc Disord. 2019 Nov 29;19(1):275. doi: 10.1186/s12872-019-1264-3.
5
Temporal Trends in Inpatient Use of Intravascular Imaging Among Patients Undergoing Percutaneous Coronary Intervention in the United States.
JACC Cardiovasc Interv. 2018 May 14;11(9):913-915. doi: 10.1016/j.jcin.2018.01.254.
6
Temporal Trends in Coronary Angiography and Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program.
JACC Cardiovasc Interv. 2018 May 14;11(9):879-888. doi: 10.1016/j.jcin.2018.02.035.
7
Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease.
JACC Cardiovasc Interv. 2019 Feb 11;12(3):232-241. doi: 10.1016/j.jcin.2018.10.049. Epub 2019 Jan 16.
8
Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):16-24. doi: 10.1002/ccd.27712. Epub 2018 Oct 5.
9
Revascularization Strategies for the Treatment of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus.
Circ Cardiovasc Interv. 2020 Sep;13(9):e009082. doi: 10.1161/CIRCINTERVENTIONS.120.009082. Epub 2020 Sep 2.
10
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
本文引用的文献
1
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2.
2
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.
JAMA. 2015 Nov 17;314(19):2045-53. doi: 10.1001/jama.2015.13764.
3
Appropriateness of percutaneous coronary intervention.
JAMA. 2011 Jul 6;306(1):53-61. doi: 10.1001/jama.2011.916.
4
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
J Am Coll Cardiol. 2009 Feb 10;53(6):530-53. doi: 10.1016/j.jacc.2008.10.005.
5
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
Zotero 插件